Furthermore, ANRIL overexpression promoted NSCLC cell proliferation and repressed apoptosis by silencing KLF2 and p21 transcription through directly binding with EZH2 [25]. Here, CDKN2B-AS1 is linked to non-small cell lung carcinoma.